Ultragenyx Tangible Assets Book Value per Share from 2010 to 2024

RARE Stock  USD 46.69  0.13  0.28%   
Check Ultragenyx financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Ultragenyx main balance sheet or income statement drivers, such as Depreciation And Amortization of 27.3 M, Interest Expense of 69.3 M or Selling General Administrative of 325.3 M, as well as many exotic indicators such as Price To Sales Ratio of 7.69, Dividend Yield of 0.0028 or Operating Cycle of 319. Ultragenyx financial statements analysis is a perfect complement when working with Ultragenyx Valuation or Volatility modules.
  
This module can also supplement Ultragenyx's financial leverage analysis and stock options assessment as well as various Ultragenyx Technical models . Check out the analysis of Ultragenyx Correlation against competitors.
For information on how to trade Ultragenyx Stock refer to our How to Trade Ultragenyx Stock guide.

About Ultragenyx Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Ultragenyx income statement, its balance sheet, and the statement of cash flows. Ultragenyx investors use historical funamental indicators, such as Ultragenyx's Tangible Assets Book Value per Share, to determine how well the company is positioned to perform in the future. Although Ultragenyx investors may use each financial statement separately, they are all related. The changes in Ultragenyx's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Ultragenyx's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Ultragenyx Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Ultragenyx. Please read more on our technical analysis and fundamental analysis pages.
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Ultragenyx Pharmaceutical Inc. was incorporated in 2010 and is headquartered in Novato, California. Ultragenyx Pharmaceu operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 1119 people.

Currently Active Assets on Macroaxis

When determining whether Ultragenyx is a strong investment it is important to analyze Ultragenyx's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Ultragenyx's future performance. For an informed investment choice regarding Ultragenyx Stock, refer to the following important reports:
Check out the analysis of Ultragenyx Correlation against competitors.
For information on how to trade Ultragenyx Stock refer to our How to Trade Ultragenyx Stock guide.
You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.

Complementary Tools for Ultragenyx Stock analysis

When running Ultragenyx's price analysis, check to measure Ultragenyx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ultragenyx is operating at the current time. Most of Ultragenyx's value examination focuses on studying past and present price action to predict the probability of Ultragenyx's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ultragenyx's price. Additionally, you may evaluate how the addition of Ultragenyx to your portfolios can decrease your overall portfolio volatility.
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Bonds Directory
Find actively traded corporate debentures issued by US companies
Transaction History
View history of all your transactions and understand their impact on performance
Global Correlations
Find global opportunities by holding instruments from different markets
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Is Ultragenyx's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ultragenyx. If investors know Ultragenyx will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ultragenyx listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(8.25)
Revenue Per Share
5.905
Quarterly Revenue Growth
0.233
Return On Assets
(0.23)
Return On Equity
(1.93)
The market value of Ultragenyx is measured differently than its book value, which is the value of Ultragenyx that is recorded on the company's balance sheet. Investors also form their own opinion of Ultragenyx's value that differs from its market value or its book value, called intrinsic value, which is Ultragenyx's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ultragenyx's market value can be influenced by many factors that don't directly affect Ultragenyx's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ultragenyx's value and its price as these two are different measures arrived at by different means. Investors typically determine if Ultragenyx is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ultragenyx's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.